Literature DB >> 23827972

Pain and suicidality: insights from reward and addiction neuroscience.

Igor Elman1, David Borsook, Nora D Volkow.   

Abstract

Suicidality is exceedingly prevalent in pain patients. Although the pathophysiology of this link remains unclear, it may be potentially related to the partial congruence of physical and emotional pain systems. The latter system's role in suicide is also conspicuous during setbacks and losses sustained in the context of social attachments. Here we propose a model based on the neural pathways mediating reward and anti-reward (i.e., allostatic adjustment to recurrent activation of the reward circuitry); both are relevant etiologic factors in pain, suicide and social attachments. A comprehensive literature search on neurobiology of pain and suicidality was performed. The collected articles were critically reviewed and relevant data were extracted and summarized within four key areas: (1) physical and emotional pain, (2) emotional pain and social attachments, (3) pain- and suicide-related alterations of the reward and anti-reward circuits as compared to addiction, which is the premier probe for dysfunction of these circuits and (4) mechanistically informed treatments of co-occurring pain and suicidality. Pain-, stress- and analgesic drugs-induced opponent and proponent states of the mesolimbic dopaminergic pathways may render reward and anti-reward systems vulnerable to sensitization, cross-sensitization and aberrant learning of contents and contexts associated with suicidal acts and behaviors. These findings suggest that pain patients exhibit alterations in the brain circuits mediating reward (depressed function) and anti-reward (sensitized function) that may affect their proclivity for suicide and support pain and suicidality classification among other "reward deficiency syndromes" and a new proposal for "enhanced anti-reward syndromes". We suggest that interventions aimed at restoring the balance between the reward and anti-reward networks in patients with chronic pain may help decreasing their suicide risk. Published by Elsevier Ltd.

Entities:  

Keywords:  ACC; AMY; Aberrant learning; Allostasis; Anti-reward; BLA; BNST; CEA; CRF; Cross-sensitization; DA; DBS; DMN; DRG; DSM-IV TR; Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision; GABA; HB; HT; Habenula; Homeostasis; INS; LC; NAc; NE; NR; PAG; PFC; PTSD; RF; S(1); S(2); Stress; VT; amygdala; anterior cingulate gyrus; basolateral complex of the amygdala; bed nucleus the striaterminalis; central nucleus of the amygdala; corticotropin-releasing factor; deep brain stimulation; default-mode network; dopamine; dorsal root ganglion; gamma-aminobutyricacid; habenula; hypothalamus; insula; locus coeruleus; norepinephrine; nucleus accumbens; periaqueductal gray matter; posttraumatic stress disorder; prefrontal cortex; primary somatosensory cortex; raphe nuclei; reticular formation nuclei; secondary somatosensory cortex; ventral tegmentum

Mesh:

Year:  2013        PMID: 23827972      PMCID: PMC4827340          DOI: 10.1016/j.pneurobio.2013.06.003

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  428 in total

1.  Comparison of two positive reinforcing stimuli: pups and cocaine throughout the postpartum period.

Authors:  B J Mattson; S Williams; J S Rosenblatt; J I Morrell
Journal:  Behav Neurosci       Date:  2001-06       Impact factor: 1.912

2.  Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission.

Authors:  Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Frank Telang; Millard Jayne; Christopher Wong
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

Review 3.  Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences.

Authors:  Nora D Volkow; Ting-Kai Li
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

4.  Structural changes of the brain in rheumatoid arthritis.

Authors:  Karolina Wartolowska; Morgan G Hough; Mark Jenkinson; Jesper Andersson; B Paul Wordsworth; Irene Tracey
Journal:  Arthritis Rheum       Date:  2012-02

Review 5.  Affective neuroscientific and neuropsychoanalytic approaches to two intractable psychiatric problems: why depression feels so bad and what addicts really want.

Authors:  Margaret R Zellner; Douglas F Watt; Mark Solms; Jaak Panksepp
Journal:  Neurosci Biobehav Rev       Date:  2011-01-15       Impact factor: 8.989

6.  Impulsivity and suicidality: the mediating role of painful and provocative experiences.

Authors:  Theodore W Bender; Kathryn H Gordon; Konrad Bresin; Thomas E Joiner
Journal:  J Affect Disord       Date:  2010-08-16       Impact factor: 4.839

7.  Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli.

Authors:  Zisis Bimpisidis; Maria Antonietta De Luca; Augusta Pisanu; Gaetano Di Chiara
Journal:  Eur J Neurosci       Date:  2012-12-06       Impact factor: 3.386

Review 8.  Hypothalamus and headaches.

Authors:  P Cortelli; G Pierangeli
Journal:  Neurol Sci       Date:  2007-05       Impact factor: 3.307

9.  Why is morphine not the ultimate analgesic and what can be done to improve it?

Authors:  C Stein; M Schäfer; H Machelska
Journal:  J Pain       Date:  2000-09       Impact factor: 5.820

10.  Intrinsic brain network abnormalities in migraines without aura revealed in resting-state fMRI.

Authors:  Ting Xue; Kai Yuan; Ling Zhao; Dahua Yu; Limei Zhao; Tao Dong; Ping Cheng; Karen M von Deneen; Wei Qin; Jie Tian
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more
  71 in total

Review 1.  Cortico-limbic pain mechanisms.

Authors:  Jeremy M Thompson; Volker Neugebauer
Journal:  Neurosci Lett       Date:  2018-11-29       Impact factor: 3.046

2.  Antinociceptive Interactions between the Imidazoline I2 Receptor Agonist 2-BFI and Opioids in Rats: Role of Efficacy at the μ-Opioid Receptor.

Authors:  Justin N Siemian; Samuel Obeng; Yan Zhang; Yanan Zhang; Jun-Xu Li
Journal:  J Pharmacol Exp Ther       Date:  2016-04-07       Impact factor: 4.030

3.  Microglia disrupt mesolimbic reward circuitry in chronic pain.

Authors:  Anna M W Taylor; Annie Castonguay; Alison J Taylor; Niall P Murphy; Atefeh Ghogha; Christopher Cook; Lihua Xue; Mary C Olmstead; Yves De Koninck; Christopher J Evans; Catherine M Cahill
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

4.  The affective dimension of pain as a risk factor for drug and alcohol addiction.

Authors:  Dana M LeBlanc; M Adrienne McGinn; Christy A Itoga; Scott Edwards
Journal:  Alcohol       Date:  2015-05-01       Impact factor: 2.405

Review 5.  Descending pain modulation and chronification of pain.

Authors:  Michael H Ossipov; Kozo Morimura; Frank Porreca
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

Review 6.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

Review 7.  Corticolimbic circuitry in the modulation of chronic pain and substance abuse.

Authors:  Anna M W Taylor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-05-10       Impact factor: 5.067

Review 8.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

9.  Topography of microglial activation in sensory- and affect-related brain regions in chronic pain.

Authors:  Anna M W Taylor; Sadaf Mehrabani; Steve Liu; Alison J Taylor; Catherine M Cahill
Journal:  J Neurosci Res       Date:  2016-08-30       Impact factor: 4.164

Review 10.  Translating the Habenula-From Rodents to Humans.

Authors:  Laura-Joy Boulos; Emmanuel Darcq; Brigitte Lina Kieffer
Journal:  Biol Psychiatry       Date:  2016-06-07       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.